SOPHiA GENETICS to Report Second Quarter 2021 Financial Results on September 9, 2021

Rhea-AI Summary

SOPHiA GENETICS (Nasdaq: SOPH) announced that it will release its financial results for Q2 2021 on September 9, 2021, before market opening. A conference call will follow at 8:30 a.m. ET to discuss these results, business developments, and future outlook. The company emphasizes its commitment to data-driven medicine through its SOPHiA DDM™ Platform, utilized by over 780 healthcare institutions globally, reinforcing its strategic position in the healthcare technology landscape.

Positive

• SOPHiA DDM™ Platform used by over 780 institutions.
• Focus on establishing data-driven medicine as standard care.

Negative

• None.

BOSTON and LAUSANNE, Switzerland, Aug. 26, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report financial results for the second quarter of 2021 before market open on Thursday, September 9, 2021. The company’s management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time to discuss its results, business developments, and outlook.

Live audio of the webcast will be available on the “Investors” section of the company website at: ir.sophiagenetics.com. An archived replay will be available on the company’s website following the event.

About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 780 hospital, laboratory, and biopharma institutions globally.

Media Contact:
sophiagenetics@consortpartners.com

Investor Contact:
ir@sophiagenetics.com

Carrie Mendivil
carrie@gilmartinir.com

FAQ

When will SOPHiA GENETICS report its Q2 2021 financial results?

SOPHiA GENETICS will report its Q2 2021 financial results on September 9, 2021.

What time is the SOPHiA GENETICS conference call for Q2 2021 results?

The conference call will begin at 8:30 a.m. Eastern Time on September 9, 2021.

Where can I listen to the SOPHiA GENETICS financial results webcast?

The webcast will be available on the 'Investors' section of the SOPHiA GENETICS website.

What is the focus of SOPHiA GENETICS in healthcare technology?

SOPHiA GENETICS is focused on establishing data-driven medicine as the standard of care.